NEWCASTLE, England, July 29 (UPI) -- Researchers in England have identified a large group of genes that may be significant for better testing and treatment of prostate cancer.
Glycan sugar groups on the surface of prostate cancer cells were found to react to changes in testosterone levels that help the disease grow and spread, and may prove to be a good target for treatment, researchers at Newcastle University report in a study published in the journal EBioMedicine.